PQS Phoqus

RNS Number:6198M
Phoqus Pharmaceuticals PLC
25 January 2008





                           Phoqus Pharmaceuticals plc



                           Directors' share dealings





West Malling, UK, 25 January 2008: Phoqus Pharmaceuticals plc (AIM: PQS)
("Phoqus" or the "Company"), the drug development company, announces that on 23
January 2008, Dr Peter Johnson, Chief Financial Officer of Phoqus, transferred
106,706 ordinary shares ("Shares") in the Company to exercising option-holders
in his capacity as nominee shareholder.



As previously announced, share options granted by the Company on 3 November 2005
were to be satisfied by the transfer of Shares held by certain institutional
shareholders. In order to facilitate the transfer of Shares to option-holders,
some of the institutional shareholders transferred Shares to Dr Peter Johnson,
Chief Financial Officer, to hold the Shares as their nominee pending exercise of
the share options by the option-holders, after which he would transfer the
relevant Shares to the exercising option-holders.



Following the above transfer of 106,706 Shares to the exercising option-holders
on 23 January 2008, 2,537 Shares are now held by Dr Johnson in his capacity as
nominee, representing less than 0.01 per cent of the issued share capital of the
Company.  Dr Johnson's beneficial ownership of Phoqus Shares remains unchanged
at 294,926 ordinary Shares, or 0.64 per cent of the issued share capital of the
Company.





Enquiries:

Phoqus Pharmaceuticals plc
Suzanne Smith, Company Secretary             Tel:  01732 870227

Nomura Code Securities Limited
Phil Walker                                  Tel:  020 7776 1200




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSEAXFSADFPEFE

Phoqus (LSE:PQS)
Historical Stock Chart
From May 2024 to Jun 2024

Phoqus (LSE:PQS)
Historical Stock Chart
From Jun 2023 to Jun 2024